OncoZenge AB (publ) (ONCOZ.ST)

SEK 3.97

(4.34%)

Eps Summary of OncoZenge AB (publ)

  • OncoZenge AB (publ)'s latest annual eps in 2023 was -1.36 SEK , up 65.83% from previous year.
  • OncoZenge AB (publ)'s latest quarterly eps in 2024 Q2 was -0.18 SEK , up 10.0% from previous quarter.
  • OncoZenge AB (publ) reported an annual eps of -3.98 SEK in 2022, down -1106.06% from previous year.
  • OncoZenge AB (publ) reported an annual eps of -0.33 SEK in 2021, down -655.15% from previous year.
  • OncoZenge AB (publ) reported a quarterly eps of -0.18 SEK for 2024 Q2, up 10.0% from previous quarter.
  • OncoZenge AB (publ) reported a quarterly eps of -0.35 SEK for 2023 Q1, up 10.26% from previous quarter.

Annual Eps Chart of OncoZenge AB (publ) (2023 - 2020)

Historical Annual Eps of OncoZenge AB (publ) (2023 - 2020)

Year Eps Eps Growth
2023 -1.36 SEK 65.83%
2022 -3.98 SEK -1106.06%
2021 -0.33 SEK -655.15%
2020 -0.04 SEK 0.0%

Peer Eps Comparison of OncoZenge AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK -147.273%
Ziccum AB (publ) -1.54 SEK 11.688%
Modus Therapeutics Holding AB (publ) -1.01 SEK -34.653%
BioArctic AB (publ) 2.60 SEK 152.308%
Sprint Bioscience AB (publ) -0.01 SEK -21487.302%
Mendus AB (publ) -4.40 SEK 69.091%
Genovis AB (publ.) 0.94 SEK 244.681%
Intervacc AB (publ) -1.69 SEK 19.527%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -518.182%
Active Biotech AB (publ) -0.17 SEK -700.0%
Magle Chemoswed Holding AB (publ) 1.13 SEK 220.354%
Bio-Works Technologies AB (publ) -1.57 SEK 13.376%
Aptahem AB (publ) -0.05 SEK -2715.735%
Vicore Pharma Holding AB (publ) -3.22 SEK 57.764%
Kancera AB (publ) -0.80 SEK -70.0%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 86.332%
Fluicell AB (publ) -0.24 SEK -466.667%
Saniona AB (publ) -1.29 SEK -5.426%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -615.789%
Biovica International AB (publ) -2.14 SEK 36.449%
Spago Nanomedical AB (publ) -0.43 SEK -216.279%
AcouSort AB (publ) -1.29 SEK -5.426%
Xintela AB (publ) -0.13 SEK -946.154%
Abliva AB (publ) -0.09 SEK -1404.425%
Egetis Therapeutics AB (publ) -1.27 SEK -7.087%
Karolinska Development AB (publ) 0.02 SEK 6900.0%
Amniotics AB (publ) -0.01 SEK -12263.636%
2cureX AB (publ) -1.85 SEK 26.486%
CombiGene AB (publ) -1.80 SEK 24.444%
Asarina Pharma AB (publ) -0.57 SEK -138.596%
Calliditas Therapeutics AB (publ) -8.69 SEK 84.35%
Camurus AB (publ) 7.78 SEK 117.481%
Corline Biomedical AB -0.08 SEK -1515.202%
IRLAB Therapeutics AB (publ) -3.43 SEK 60.35%
Isofol Medical AB (publ) -0.23 SEK -491.304%
I-Tech AB 1.70 SEK 180.0%
Hansa Biopharma AB (publ) -15.83 SEK 91.409%
Cyxone AB (publ) -0.22 SEK -518.182%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 31.313%
Biosergen AB -0.60 SEK -126.667%
Cantargia AB (publ) -1.65 SEK 17.576%
NextCell Pharma AB -1.03 SEK -32.039%
Xspray Pharma AB (publ) -6.76 SEK 79.882%
Elicera Therapeutics AB (publ) -0.83 SEK -63.855%
Nanologica AB (publ) -2.05 SEK 33.659%
SynAct Pharma AB -6.64 SEK 79.518%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -423.077%
Stayble Therapeutics AB (publ) -0.92 SEK -47.826%
LIDDS AB (publ) -0.63 SEK -115.873%
Lipum AB (publ) -4.45 SEK 69.438%
BioInvent International AB (publ) -5.02 SEK 72.908%
Alzinova AB (publ) -0.41 SEK -231.707%
Oncopeptides AB (publ) -1.96 SEK 30.612%
Pila Pharma AB (publ) -0.47 SEK -189.362%
Guard Therapeutics International AB (publ) -11.26 SEK 87.922%
Scandinavian ChemoTech AB (publ) -1.13 SEK -20.354%
Simris Alg AB (publ) -0.16 SEK -750.0%
Diamyd Medical AB (publ) -1.60 SEK 15.0%
Xbrane Biopharma AB (publ) -1.27 SEK -7.087%
Ascelia Pharma AB (publ) -3.24 SEK 58.025%
Diagonal Bio AB (publ) -0.32 SEK -325.0%